The Offering raised net cash proceeds of approximately $2.9 million (after deducting the transfer agent and legal fees and expenses of the Offering). The Company intends to use the net cash proceeds ...
Innovative targeted oncology company built on next-generation ADCs and a novel discovery engineConnect with the Company on Webull hereBOSTON and ...